SCHEMBL6327115

SCHEMBL6327115

Cc1cc2c(NCc3cc(C(=N)NC(=O)c4ccccc4)ccc3O)ncnc2cc1C(=O)N1CCCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 2/20 0.37
ALDH1A1 P00352 4/20 0.36
HPGD P15428 2/20 0.36
HTT P42858 2/20 0.36
PDE5A O76074 2/20 0.36
EGFR P00533 5/20 0.36
KDR P35968 1/20 0.35
PPARG P37231 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
NR2E3 Q9Y5X4 1/20 0.35
NCOR2 Q9Y618 1/20 0.35
MAPK1 P28482 3/20 0.35
LMNA P02545 2/20 0.35
AURKB Q96GD4 2/20 0.35
USP2 O75604 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2D6 P10635 2/20 0.35
CYP2C19 P33261 2/20 0.35
HSD17B10 Q99714 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6322214 0.92 CDK1 (0.39) CDK1ALDH1A1HPGDHTTPDE5A
SCHEMBL6323136 0.89 HPGD (0.38) CDK1ALDH1A1HPGDHTTPDE5A
SCHEMBL2989697 0.89 HPGD (0.41) CDK1ALDH1A1HPGDHTTPDE5A
SCHEMBL3000544 0.89 CDK1 (0.40) CDK1ALDH1A1HPGDHTTPDE5A
SCHEMBL2991625 0.86 F10 (0.41) CDK1ALDH1A1HPGDHTTPDE5A
SCHEMBL2995881 0.85 PDE5A (0.36) CDK1ALDH1A1HPGDHTTPDE5A
SCHEMBL8312292 0.84 CDK1 (0.36) CDK1ALDH1A1HPGDHTTPDE5A
SCHEMBL6324414 0.80 EGFR (0.39) CDK1ALDH1A1HPGDHTTPDE5A
SCHEMBL6327108 0.80 KMT2A (0.34) ALDH1A1HPGDLMNAMEN1POLB
SCHEMBL6554900 0.79 CACNA1B (0.41) ALDH1A1HPGDHTTLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050107409-A1 Aromatic bicyclic compounds, preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107409-A1 Aromatic bicyclic compounds, preparation thereof and their use as pharmaceutical compositions F12, F2, F11 CDK1 170/4885ALDH1A1 1078/4885HPGD 1428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.